P53 Laboratory

The discovery of a new, highly conserved druggable site on the HIV reverse transcriptase could turn the tide in the wake of growing drug resistance.

A*STAR scientists aim to design better immunotherapies by simulating the binding of antibodies to their targets.

A*STAR scientists have developed a method to measure crucial protein-protein interactions in cancer cells, with implications for drug design and discovery.

A*STAR researchers have turned a bacterial protein into a biosensor that can be used to visualize interactions between proteins.

A better understanding of the way sugar units are attached to the surface proteins of cancer cells may help to improve targeted cancer treatments, A*STAR scientists say.

Bortezomib, a drug that inhibits the ‘waste disposal system’ in animal cells, could be used to suppress cell division in cancer.

Adapted polymer offers plant-based protection from the Sun’s harmful rays